---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-024952"
form_type: "8-K/A"
ticker: "PVLA"
cik: "0001583648"
company_name: "PALVELLA THERAPEUTICS, INC."
filed_at: "2023-08-31T23:59:59+00:00"
generated_at: "2026-06-11T01:12:27.464078+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pieris adds $3.4M retention & severance costs to July 2023 restructuring estimate

## Summary
- Compensation Committee approved retention benefits for non-executive employees on Aug 30, 2023.
- Total estimated retention, severance and related costs now ~$3.4M through Q2 2024.
- This amount is in addition to severance costs originally reported in the July 18, 2023 8-K.
- Amendment filed solely to update cost estimates; no other changes to prior disclosures.

## SEC filing metadata
- accession: 0001437749-23-024952
- form_type: 8-K/A
- ticker: PVLA
- cik: 0001583648
- company_name: PALVELLA THERAPEUTICS, INC.
- filed_at: 2023-08-31T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.05, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583648/000143774923024952/0001437749-23-024952-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583648/000143774923024952/pirs20230823c_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-024952
- JSON: https://secwatch.observer/filing/0001437749-23-024952.json
- Plain text: https://secwatch.observer/filing/0001437749-23-024952.txt

## Key facts
- Restructurings & Charges
  PALVELLA THERAPEUTICS, INC. announced a restructuring with charges of approximately $3.4 million affecting Workplace Restructuring.
  - Type: restructuring
  - Charge: approximately $3.4 million
  - Affected area: Workplace Restructuring
  source text: As a result of the Workplace Restructuring, the Company expects to incur estimated retention benefits, severance and related costs of approximately $3.4 million through the second quarter of 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1583648/000143774923024952/0001437749-23-024952-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
